A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
Completed · Phase 1
Conditions studied: Restless Legs Syndrome
In brief
This study will investigate the effects of severe renal impairment and hemodialysis on the characteristics of the drug, ropinirole.
Key facts
- Study ID
- NCT00422994
- Run by
- GlaxoSmithKline
- People needed
- 48
- Starts
- 2006-04-01
- Expected to finish
- 2006-12-01
- Last updated by the study team
- 2016-10-26
Who can join
Age: 18 and older, up to 79. Sex: any. Healthy volunteers: accepted.
Where it is running
- GSK Investigational Site — Minneapolis, Minnesota, United States
- GSK Investigational Site — London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.